HBC(SH:603077) Mei Ri Jing Ji Xin Wen·2025-12-05 08:57Core Viewpoint - The news clarifies that Hebang Bio (SH603077) did not invest in the 1.5 billion yuan lithium carbonate (lithium hydroxide) project; rather, it was a decision made by its controlling shareholder [2][3][4]. Group 1: Project Details - The total investment for the Hebang Fushun lithium carbonate (lithium hydroxide) project is 1.5 billion yuan, located in Fushun County, Zigong City, Sichuan Province [3][4]. - The project was signed on December 1, leading to a stock price surge for Hebang Bio, which reached its daily limit [4]. - The controlling shareholder, Sichuan Hebang Investment Group, is committed to leveraging its core advantages in resource integration and technology development for the project [3][4]. Group 2: Market Context and Strategic Moves - Hebang Bio is transitioning from traditional chemical industries to new energy sectors, including photovoltaic glass and lithium battery materials, as part of its strategy for growth and industrial upgrade [3][4]. - The company has established a diversified business layout, including mining, chemicals, and photovoltaic glass, with significant production capacities in various minerals [5]. - The lithium industry in Zigong has advantages in lithium extraction from brine, which has been successfully tested in collaboration with local companies [6]. Group 3: Industry Insights - The lithium extraction project in Zigong is notable for its brine extraction method, which has been validated through successful trials [6]. - The local government has confirmed substantial lithium resources, estimating potential lithium carbonate reserves of 178,600 tons [6].